Tumor treating fields (TTFields) augment antitumor and immune activity of immunochemotherapy in preclinical models of non-small cell lung cancer

Category Primary study
ConferenceESMO Open Science for Optimal Cancer Care
Year 2026
This article has no abstract
Epistemonikos ID: 455109c3c96fb2f091f98490a082e85cbe5c823c
First added on: Apr 04, 2026